Literature DB >> 18508607

Modulation of tumor associated macrophages in solid tumors.

Trevor Lucas1, Dietmar Abraham, Seyedhossein Aharinejad.   

Abstract

It is becoming increasingly clear that interactions between cancer cells, stroma cells and the extracellular matrix (ECM) are pivotal to the processes of neovascularization and tumorigenesis. As tumor stromal components known as tumor associated macrophages (TAMs), mononuclear phagocytes can play a key role in tumor type specific neoangiogenesis by promoting remodeling of the ECM through the production of matrix metalloproteases (MMPs), secreting pro-angiogenic growth factors and stabilizing the tumor vasculature. The growth factor colony-stimulating factor-1 is produced by a wide variety of cancer cells and tumor stroma cells and influences the migration, survival and phenotype of TAMs. Thus, understanding the relationships of the cancer cell with the host environment is key for specifically exploiting tumor growth promoting tumor host interactions for new therapeutic strategies. This review outlines the strategies for targeting CSF-1 in malignancies to influence TAMs in tumor development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508607     DOI: 10.2741/3101

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  13 in total

1.  Krüppel-like factor 4 regulates macrophage polarization.

Authors:  Xudong Liao; Nikunj Sharma; Fehmida Kapadia; Guangjin Zhou; Yuan Lu; Hong Hong; Kaavya Paruchuri; Ganapati H Mahabeleshwar; Elise Dalmas; Nicolas Venteclef; Chris A Flask; Julian Kim; Bryan W Doreian; Kurt Q Lu; Klaus H Kaestner; Anne Hamik; Karine Clément; Mukesh K Jain
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

2.  Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.

Authors:  Vinit Kumar; Laxminarasimha Donthireddy; Douglas Marvel; Thomas Condamine; Fang Wang; Sergio Lavilla-Alonso; Ayumi Hashimoto; Prashanthi Vonteddu; Reeti Behera; Marlee A Goins; Charles Mulligan; Brian Nam; Neil Hockstein; Fred Denstman; Shanti Shakamuri; David W Speicher; Ashani T Weeraratna; Timothy Chao; Robert H Vonderheide; Lucia R Languino; Peter Ordentlich; Qin Liu; Xiaowei Xu; Albert Lo; Ellen Puré; Chunsheng Zhang; Andrey Loboda; Manuel A Sepulveda; Linda A Snyder; Dmitry I Gabrilovich
Journal:  Cancer Cell       Date:  2017-11-13       Impact factor: 31.743

3.  PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.

Authors:  Y Zheng; J Yang; J Qian; P Qiu; S Hanabuchi; Y Lu; Z Wang; Z Liu; H Li; J He; P Lin; D Weber; R E Davis; L Kwak; Z Cai; Q Yi
Journal:  Leukemia       Date:  2012-09-21       Impact factor: 11.528

Review 4.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

5.  When neighbourhood matters: tumour microenvironment.

Authors:  M Pérez-Moreno
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

6.  Phenotypic and functional delineation of murine CX(3)CR1 monocyte-derived cells in ovarian cancer.

Authors:  Kevin M Hart; S Peter Bak; Anselmo Alonso; Brent Berwin
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

7.  Transcription factor ATF3 links host adaptive response to breast cancer metastasis.

Authors:  Chris C Wolford; Stephen J McConoughey; Swati P Jalgaonkar; Marino Leon; Anand S Merchant; Johnna L Dominick; Xin Yin; Yiseok Chang; Erik J Zmuda; Sandra A O'Toole; Ewan K A Millar; Stephanie L Roller; Charles L Shapiro; Michael C Ostrowski; Robert L Sutherland; Tsonwin Hai
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

8.  Hypoxia potentiates glioma-mediated immunosuppression.

Authors:  Jun Wei; Adam Wu; Ling-Yuan Kong; Yongtao Wang; Gregory Fuller; Isabella Fokt; Giovanni Melillo; Waldemar Priebe; Amy B Heimberger
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

Review 9.  From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors.

Authors:  Oana Draghiciu; Hans W Nijman; Toos Daemen
Journal:  Clin Dev Immunol       Date:  2011-12-08

10.  Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in mice.

Authors:  Trevor Lucas; Dietmar Abraham; Gerold Untergasser; Karin Zins; Erhard Hofer; Eberhard Gunsilius; Seyedhossein Aharinejad
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.